tiprankstipranks
Blueberries Medical Corp (BBRRF)
OTHER OTC:BBRRF
US Market
BBRRF
Blueberries Medical
RESEARCH TOOLSreports
Want to see BBRRF full AI Analyst Report?

Blueberries Medical (BBRRF) Ratios

52 Followers

Blueberries Medical Ratios

BBRRF's free cash flow for Q4 2025 was C$―. For the 2025 fiscal year, BBRRF's free cash flow was decreased by C$ and operating cash flow was C$―. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 0.95 ― 1.84 4.15 1.25
Quick Ratio
 0.88 ― 1.39 3.59 1.24
Cash Ratio
 0.07 ― 0.12 1.78 0.81
Solvency Ratio
 -4.37 ― -1.91 -3.16 -0.62
Operating Cash Flow Ratio
 -3.47 ― -1.46 -2.90 -0.84
Short-Term Operating Cash Flow Coverage
 -173.01 ― -69.64 0.00 -1.28
Net Current Asset Value
C$ 448.83KC$ ―C$ 457.39KC$ 1.44MC$ 299.25K
Leverage Ratios
Debt-to-Assets Ratio
 0.01 ― <0.01 <0.01 0.40
Debt-to-Equity Ratio
 0.02 ― 0.01 <0.01 0.91
Debt-to-Capital Ratio
 0.02 ― 0.01 <0.01 0.48
Long-Term Debt-to-Capital Ratio
 0.00 ― 0.00 0.00 0.00
Financial Leverage Ratio
 2.12 ― 1.65 1.24 2.29
Debt Service Coverage Ratio
 -175.80 ― -91.18 -4.63 -0.17
Interest Coverage Ratio
 -18.89K ― 0.00 -5.22 -4.56
Debt to Market Cap
 <0.01 ― <0.01 0.00 0.45
Interest Debt Per Share
 <0.01 ― <0.01 <0.01 0.01
Net Debt to EBITDA
 <0.01 ― 0.05 0.66 0.09
Profitability Margins
Gross Profit Margin
31.93%―34.90%29.22%-7.53%
EBIT Margin
-440.07%―-243.64%-475.78%-470.50%
EBITDA Margin
-408.59%―-221.32%-423.83%-344.65%
Operating Profit Margin
-441.57%―-193.70%-477.44%-696.79%
Pretax Profit Margin
-533.44%―-243.64%-567.30%-623.44%
Net Profit Margin
-533.44%―-243.64%-567.30%-623.44%
Continuous Operations Profit Margin
-533.44%―-243.64%-567.30%-623.44%
Net Income Per EBT
100.00%―100.00%100.00%100.00%
EBT Per EBIT
120.81%―125.78%118.82%89.47%
Return on Assets (ROA)
-132.05%―-83.20%-67.67%-43.76%
Return on Equity (ROE)
-167.41%―-137.58%-84.04%-100.01%
Return on Capital Employed (ROCE)
-175.44%―-109.38%-70.33%-102.11%
Return on Invested Capital (ROIC)
-172.96%―-106.46%-70.27%-36.57%
Return on Tangible Assets
-132.05%―-83.20%-67.67%-43.76%
Earnings Yield
-20.92%―-28.78%-37.29%-57.94%
Efficiency Ratios
Receivables Turnover
 1.11 ― 1.20 0.93 0.92
Payables Turnover
 1.08 ― 0.59 0.47 0.56
Inventory Turnover
 8.16 ― 1.25 0.78 20.56
Fixed Asset Turnover
 23.89 ― 1.25 0.57 0.20
Asset Turnover
 0.46 ― 0.34 0.12 0.07
Working Capital Turnover Ratio
 1.45 ― 0.49 0.31 7.13
Cash Conversion Cycle
 2.08 ― -20.04 77.76 -233.44
Days of Sales Outstanding
 200.28 ― 303.08 392.97 396.74
Days of Inventory Outstanding
 296.19 ― 291.40 466.36 17.75
Days of Payables Outstanding
 494.39 ― 614.52 781.57 647.93
Operating Cycle
 496.47 ― 594.47 859.33 414.49
Cash Flow Ratios
Operating Cash Flow Per Share
 >-0.01 ― >-0.01 >-0.01 >-0.01
Free Cash Flow Per Share
 >-0.01 ― >-0.01 >-0.01 >-0.01
CapEx Per Share
 <0.01 ― 0.00 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 ― 1.00 1.02 1.00
Dividend Paid and CapEx Coverage Ratio
 -310.77K ― 0.00 -59.61 -489.52K
Capital Expenditure Coverage Ratio
 -310.77K ― 0.00 -59.61 -489.52K
Operating Cash Flow Coverage Ratio
 -173.01 ― -69.64 -104.07 -1.10
Operating Cash Flow to Sales Ratio
 -3.98 ― -1.69 -4.62 -6.24
Free Cash Flow Yield
-17.61%―-19.97%-30.89%-57.97%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -4.46 ― -3.47 -2.68 -1.73
Price-to-Sales (P/S) Ratio
 23.78 ― 8.46 15.21 10.76
Price-to-Book (P/B) Ratio
 23.12 ― 4.78 2.25 1.73
Price-to-Free Cash Flow (P/FCF) Ratio
 -5.97 ― -5.01 -3.24 -1.73
Price-to-Operating Cash Flow Ratio
 -5.97 ― -5.01 -3.29 -1.73
Price-to-Earnings Growth (PEG) Ratio
 0.11 ― 0.06 0.19 0.02
Price-to-Fair Value
 23.12 ― 4.78 2.25 1.73
Enterprise Value Multiple
 -5.81 ― -3.77 -2.93 -3.03
Enterprise Value
 7.41M ― 3.94M 3.58M 2.46M
EV to EBITDA
 -5.15 ― -3.77 -2.93 -3.03
EV to Sales
 17.91 ― 8.35 12.42 10.44
EV to Free Cash Flow
 -5.67 ― -4.94 -2.64 -1.67
EV to Operating Cash Flow
 -5.67 ― -4.94 -2.69 -1.67
Tangible Book Value Per Share
 <0.01 ― <0.01 <0.01 <0.01
Shareholders’ Equity Per Share
 <0.01 ― <0.01 <0.01 <0.01
Tax and Other Ratios
Effective Tax Rate
 0.00 ― 0.00 0.00 0.37
Revenue Per Share
 <0.01 ― <0.01 <0.01 <0.01
Net Income Per Share
 >-0.01 ― >-0.01 >-0.01 >-0.01
Tax Burden
 1.00 ― 1.00 1.00 1.00
Interest Burden
 1.01 ― 1.00 1.19 1.33
Research & Development to Revenue
 0.00 ― 0.00 0.00 0.00
SG&A to Revenue
 3.35 ― 2.06 4.29 5.21
Stock-Based Compensation to Revenue
 0.04 ― 0.10 0.39 0.57
Income Quality
 0.84 ― 0.69 0.81 1.00
Currency in CAD